<?xml version="1.0" encoding="UTF-8"?>
<table-wrap id="Tab1">
 <label>Table 1</label>
 <caption>
  <p>Overview of select clinical trials and potential cardiotoxicities [
   <xref ref-type="bibr" rid="CR72">72</xref>–
   <xref ref-type="bibr" rid="CR85">85</xref>]
  </p>
 </caption>
 <table frame="hsides" rules="groups">
  <thead>
   <tr>
    <th align="left">General class</th>
    <th align="left">Drug</th>
    <th align="left">Cardiotoxicities</th>
    <th align="left">Clinical trials</th>
   </tr>
  </thead>
  <tbody>
   <tr>
    <td align="left">
     <italic>Repurposed agents targeting viral entry and replication</italic>
    </td>
    <td align="left">Hydroxychloroquine sulfate/chloroquine phosphate ± azithromycin</td>
    <td align="left">Dilated cardiomyopathy, QT prolongation</td>
    <td align="left">NCT04342221, NCT04307693, NCT04315896, NCT04329923, NCT04345692</td>
   </tr>
   <tr>
    <td align="left"/>
    <td align="left">Lopinavir/ritonavir</td>
    <td align="left">QT prolongation, rhabdomyolysis with statins</td>
    <td align="left">NCT04252885, NCT04307693, NCT04307693, NCT04255017</td>
   </tr>
   <tr>
    <td align="left"/>
    <td align="left">Remdesivir</td>
    <td align="left">?hypotension</td>
    <td align="left">NCT04292899, NCT04292730, NCT04323761, NCT04302766, NCT04280705</td>
   </tr>
   <tr>
    <td align="left">
     <italic>Repurposed agents targeting the immune system</italic>
    </td>
    <td align="left">Corticosteroids</td>
    <td align="left">Fluid retention, hypertension, electrolyte abnormalities, arrhythmia</td>
    <td align="left">NCT04343729, NCT04329650, NCT04327401, NCT04344288, NCT04331054, NCT04348305, NCT04355247</td>
   </tr>
   <tr>
    <td align="left"/>
    <td align="left">Tocilizumab</td>
    <td align="left">Hypertension, hypercholesterolemia</td>
    <td align="left">NCT04315480, NCT04320615, NCT04317092, NCT04332913, NCT04306705, NCT04310228, NCT04346355, NCT04332094, NCT04331795</td>
   </tr>
   <tr>
    <td align="left"/>
    <td align="left">Fingolimod</td>
    <td align="left">Hypertension, conduction disease, QT prolongation. Contraindicated in prior MI or known CAD, stroke, conduction disease, prolonged QT, decompensated heart failure</td>
    <td align="left">NCT04280588</td>
   </tr>
   <tr>
    <td align="left"/>
    <td align="left">Convalescent plasma</td>
    <td align="left">None reported</td>
    <td align="left">NCT04343755, NCT04346446, NCT04342182, NCT04347681, NCT04345523, NCT04344535, NCT04340050, NCT04357106, NCT04327349, NCT04292340, NCT04261426, NCT04264858, NCT04261426</td>
   </tr>
  </tbody>
 </table>
</table-wrap>
